Cargando…

Selected Aspects of Nutrition in the Prevention and Treatment of Inflammatory Bowel Disease

Inflammatory bowel disease has become a global health problem at the turn of the 21st century. The pathogenesis of this disorder has not been fully explained. In addition to non-modifiable genetic factors, a number of modifiable factors such as diet or gut microbiota have been identified. In this pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Panufnik, Paulina, Więcek, Martyna, Kaniewska, Magdalena, Lewandowski, Konrad, Szwarc, Paulina, Rydzewska, Grażyna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737796/ https://www.ncbi.nlm.nih.gov/pubmed/36500995 http://dx.doi.org/10.3390/nu14234965

Ejemplares similares

Low-FODMAP Diet for the Management of Irritable Bowel Syndrome in Remission of IBD
por: Więcek, Martyna, et al.
Publicado: (2022)

Risk Factors for Osteoporosis among Patients with Inflammatory Bowel Disease—Do We Already Know Everything?
por: Lewandowski, Konrad, et al.
Publicado: (2023)

Diet as therapeutic intervention in Crohn’s disease
por: Więcek, Martyna, et al.
Publicado: (2022)

Long-lasting dyspeptic symptoms – another consequence of the COVID-19 pandemic?
por: Nazarewska, Anna, et al.
Publicado: (2023)

Effect of Intravenous Iron Administration on Bone Mineral and Iron Homeostasis in Patients with Inflammatory Bowel Disease—Results of a Prospective Single-Centre Study
por: Tulewicz-Marti, Edyta, et al.
Publicado: (2023)

The Use of Virtual Reality to Reduce Stress among Inflammatory Bowel Disease Patients Treated with Vedolizumab
por: Lewandowski, Konrad, et al.
Publicado: (2021)

The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome
por: Lewandowski, Konrad, et al.
Publicado: (2022)

Effectiveness of Crohn’s Disease Exclusion Diet for Induction of Remission in Crohn’s Disease Adult Patients
por: Szczubełek, Martyna, et al.
Publicado: (2021)

Reply to van Lingen et al. Comment on “Szczubełek et al. Effectiveness of Crohn’s Disease Exclusion Diet for Induction of Remission in Crohn’s Disease Adult Patients. Nutrients 2021, 13, 4112”
por: Szczubełek, Martyna, et al.
Publicado: (2022)

Gastrointestinal symptoms in COVID-19
por: Lewandowski, Konrad, et al.
Publicado: (2022)

Management of anaemia in patients with inflammatory bowel disease – results of a questionnaire among Polish healthcare professionals
por: Tulewicz-Marti, Edyta M., et al.
Publicado: (2021)

Biosimilar biological drugs in the treatment of inflammatory bowel diseases
por: Kaniewska, Magdalena, et al.
Publicado: (2019)

Gastrointestinal symptoms in patients with coronavirus disease 2019 (COVID-19) – friend or foe?
por: Lewandowski, Konrad, et al.
Publicado: (2021)

Bone Metabolism Alteration in Patients with Inflammatory Bowel Disease
por: Tulewicz-Marti, Edyta Maria, et al.
Publicado: (2022)

Skin and gastrointestinal symptoms in COVID-19
por: Ciechanowicz, Piotr, et al.
Publicado: (2020)

Awareness and Compliance with the Recommendations of Primary and Secondary Prevention of Cancer in Patients with Inflammatory Bowel Disease
por: Tulewicz-Marti, Edyta, et al.
Publicado: (2023)

The introduction of the IBD Disk in Poland – a new tool for assessing disability in patients with inflammatory bowel disease
por: Eder, Piotr, et al.
Publicado: (2019)

Iron deficiency anaemia in patients with inflammatory bowel disease: National Consultant for Gastroenterology Working Group Recommendations
por: Kaniewska, Magdalena, et al.
Publicado: (2014)

The efficacy and safety of the biosimilar product (Inflectra(®)) compared to the reference drug (Remicade(®)) in rescue therapy in adult patients with ulcerative colitis
por: Kaniewska, Magdalena, et al.
Publicado: (2017)

Effective treatment of severe acute pancreatitis and COVID-19 pneumonia with tocilizumab
por: Zielecki, Piotr, et al.
Publicado: (2020)

Oxidative and Antioxidative Stress Status in Children with Inflammatory Bowel Disease as a Result of a Chronic Inflammatory Process
por: Grzybowska-Chlebowczyk, Urszula, et al.
Publicado: (2018)

Biosimilar infliximab versus originator in Crohn’s disease anti-TNF-α naïve and non-naïve patients
por: Kaniewska, Magdalena, et al.
Publicado: (2020)

Biomarkers in management of inflammatory bowel disease
por: Moniuszko, Andrzej, et al.
Publicado: (2013)

Nutritional Aspects in Inflammatory Bowel Diseases
por: Balestrieri, Paola, et al.
Publicado: (2020)

Assessment of sexual dysfunction in patients with inflammatory bowel disease
por: Szydlarska, Dorota, et al.
Publicado: (2019)

Preparation for endoscopic examinations in patients with diabetes and hypoglycaemia
por: Lewandowski, Konrad, et al.
Publicado: (2021)

Management of anemia in inflammatory bowel disease: a challenge in everyday clinical practice
por: Tulewicz-Marti, Edyta, et al.
Publicado: (2017)

New pharmaceuticals in inflammatory bowel disease
por: Łodyga, Michał, et al.
Publicado: (2015)

A Prospective Questionnaire-Based Study to Evaluate Factors Affecting the Decision to Receive COVID-19 Vaccination in 267 Patients with Inflammatory Bowel Disease in Poland
por: Łodyga, Michał, et al.
Publicado: (2022)

Nutritional aspect of pediatric inflammatory bowel disease: its clinical importance
por: Kim, Seung, et al.
Publicado: (2015)

The Role of Enteral Nutrition in Patients with Inflammatory Bowel Disease: Current Aspects
por: Triantafillidis, John K., et al.
Publicado: (2015)

Influence of the Treatment Used in Inflammatory Bowel Disease on the Protease Activities
por: Dudzińska, Ewa, et al.
Publicado: (2020)

Inflammatory bowel disease: clinical aspects and treatments
por: Fakhoury, Marc, et al.
Publicado: (2014)

The Efficacy of Mebeverine in the Treatment of Irritable Bowel Syndrome—A Systematic Review
por: Daniluk, Jaroslaw, et al.
Publicado: (2022)

Position statement of the Polish Society of Gastroenterology and the National Gastroenterology Consultant on vaccination against COVID-19 among patients with inflammatory bowel diseases
por: Eder, Piotr, et al.
Publicado: (2021)

Imaging of Morphological Background in Selected Functional and Inflammatory Gastrointestinal Diseases in fMRI
por: Skrobisz, Katarzyna, et al.
Publicado: (2020)

Clinical Aspects and Treatments for Pediatric Inflammatory Bowel Diseases
por: Moon, Jin Soo
Publicado: (2019)

Clinical aspects and treatments for pediatric inflammatory bowel diseases
por: Moon, Jin Soo
Publicado: (2019)

Biosimilar medicines – their use in the treatment of inflammatory bowel diseases. Position statement of the Working Group of the Polish National Consultant in Gastroenterology
por: Mularczyk, Aldona, et al.
Publicado: (2014)

The position statement of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology regarding the management of patients with inflammatory bowel disease during the COVID-19 pandemic
por: Łodyga, Michał, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s3l9pnqka3n98k3ge5p55uti2f